TY - JOUR
T1 - Influence of sex and gender-related factors on the knowledge of generic medicines among older patients and caregivers
AU - Ceolin, Chiara
AU - Zazzara, Maria Beatrice
AU - Salis, Francesco
AU - Macaluso, Myriam
AU - Levati, Elena
AU - Onder, Graziano
AU - Bernabei, Roberto
AU - Trevisan, Caterina
AU - D'Ignazio, Federica
AU - Rivasi, Giulia
AU - null, null
AU - Andreoli, Stefano
AU - Arena, Giada
AU - Basile, Giorgio
AU - Bellelli, Giuseppe
AU - Bellone, Federica
AU - Bencivenga, Leonardo
AU - Bernabei, Roberto
AU - Bertocco, Anna
AU - Biancone, Davide Maria
AU - Brunetti, Enrico
AU - Bulla, Maria Modestina
AU - Bursi, Maria Lucia
AU - Cacciatore, Stefano
AU - Capacci, Marco
AU - Cargiolli, Cristina
AU - Caruso, Stefano
AU - Ceolin, Ludovica
AU - Coniglio, Giuseppina
AU - Corbani, Andrea
AU - D'Errico, Antonio
AU - De Felice, Rosa
AU - Ferrara, Maria Cristina
AU - Filicetti, Elvira
AU - Finamore, Panaiotis
AU - Finco, Tommaso
AU - Fumagalli, Beatrice
AU - Geneletti, Thelma
AU - Ghidini, Alessia
AU - Giordano, Rossella
AU - Gorla, Giulia
AU - Guarneri, Claudio
AU - Lazzaro, Giovanni
AU - Lenotti, Elisa
AU - Maltese, Leonarda
AU - Montini, Davide
AU - Okoye, Chukwuma
AU - Parrotta, Ilaria
AU - Pasolini, Giulia
AU - Petrucci, Chiara
AU - Presta, Roberto
AU - Risoli, Antonella
AU - Rengo, Giuseppe
AU - Romagnoli, Priscilla
AU - Scarano, Ottavio
AU - Scaroni, Pierfederico
AU - Soraci, Luca
AU - Andrea, Ungar
AU - Agostino, Virdis
AU - Zucchelli, Alberto
PY - 2026
Y1 - 2026
N2 - Generic medicines (GMs) are bioequivalent to brand-name medicines and more cost-effective, yet their use is limited. Gender-related factors may influence attitudes toward GMs, but data on older adults are scarce. This study aimed to explore sex and gender differences in knowledge and opinions about GMs among older patients and their caregivers. SurFE is a cross-sectional multicenter survey conducted in Italy (April–May 2023) that enrolled non-institutionalized individuals aged ≥ 65 years and their caregivers. Participants completed a questionnaire assessing knowledge, attitudes, and perceptions of GMs, and sociodemographic and health-related information. We collected data on gender-specific factors and, using a validated methodology, developed a composite gender score. Among the 471 participants (312 patients and 159 caregivers), no differences related to biological sex were observed. According to the gender score, patients with male gender characteristics were less likely to believe that generic medicines are made with lower-quality substances. Additionally, both female patients and male caregivers were more likely to consider GMs equivalent to brand-name medications. As for biological sex, ordinal regression analysis adjusted for sociodemographic and educational factors showed that female caregivers were significantly more likely to believe that GMs are produced with lower-quality substances (OR 2.06, 95% CI 1.01–4.21, p = 0.047). Also, focusing on gender, male patients were more likely to believe that GMs require more time to be effective (OR 1.89, 95% CI 1.06–3.35, p = 0.030), as well as female caregivers about the belief that GMs are produced with lower-quality substances (OR 2.25, 95% CI 0.33–1.60, p = 0.037), even if not confirmed in the adjusted model. No other significant associations emerged. Attitudes toward GMs may vary by gender, but not biological sex. However, this association was not independent of socio-cultural factors and should be explored in future longitudinal research to understand and address barriers to the use of GMs.
AB - Generic medicines (GMs) are bioequivalent to brand-name medicines and more cost-effective, yet their use is limited. Gender-related factors may influence attitudes toward GMs, but data on older adults are scarce. This study aimed to explore sex and gender differences in knowledge and opinions about GMs among older patients and their caregivers. SurFE is a cross-sectional multicenter survey conducted in Italy (April–May 2023) that enrolled non-institutionalized individuals aged ≥ 65 years and their caregivers. Participants completed a questionnaire assessing knowledge, attitudes, and perceptions of GMs, and sociodemographic and health-related information. We collected data on gender-specific factors and, using a validated methodology, developed a composite gender score. Among the 471 participants (312 patients and 159 caregivers), no differences related to biological sex were observed. According to the gender score, patients with male gender characteristics were less likely to believe that generic medicines are made with lower-quality substances. Additionally, both female patients and male caregivers were more likely to consider GMs equivalent to brand-name medications. As for biological sex, ordinal regression analysis adjusted for sociodemographic and educational factors showed that female caregivers were significantly more likely to believe that GMs are produced with lower-quality substances (OR 2.06, 95% CI 1.01–4.21, p = 0.047). Also, focusing on gender, male patients were more likely to believe that GMs require more time to be effective (OR 1.89, 95% CI 1.06–3.35, p = 0.030), as well as female caregivers about the belief that GMs are produced with lower-quality substances (OR 2.25, 95% CI 0.33–1.60, p = 0.037), even if not confirmed in the adjusted model. No other significant associations emerged. Attitudes toward GMs may vary by gender, but not biological sex. However, this association was not independent of socio-cultural factors and should be explored in future longitudinal research to understand and address barriers to the use of GMs.
KW - Caregivers
KW - Gender
KW - Gender medicine
KW - Older adults
KW - Sex differences
KW - Caregivers
KW - Gender
KW - Gender medicine
KW - Older adults
KW - Sex differences
UR - https://publicatt.unicatt.it/handle/10807/340817
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105022444266&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105022444266&origin=inward
U2 - 10.1007/s11739-025-04171-3
DO - 10.1007/s11739-025-04171-3
M3 - Article
SN - 1828-0447
VL - 21
SP - 153
EP - 161
JO - Internal and Emergency Medicine
JF - Internal and Emergency Medicine
IS - 1
ER -